New Antibiotic Targets:
A crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In "New Antibiotic Targets," W. Scott Champney examines s...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2008
|
Schriftenreihe: | Methods In Molecular Medicine™
142 |
Schlagworte: | |
Online-Zugang: | UBR01 TUM01 Volltext |
Zusammenfassung: | A crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In "New Antibiotic Targets," W. Scott Champney examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies. With detailed methods and protocols for the identification and assay of these targets, "New Antibiotic Targets" provides laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases |
Beschreibung: | 1 Online-Ressource (XII, 274 p. 51 illus) |
ISBN: | 9781597452465 |
DOI: | 10.1007/978-1-59745-246-5 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV044950958 | ||
003 | DE-604 | ||
005 | 20180829 | ||
007 | cr|uuu---uuuuu | ||
008 | 180517s2008 |||| o||u| ||||||eng d | ||
020 | |a 9781597452465 |9 978-1-59745-246-5 | ||
024 | 7 | |a 10.1007/978-1-59745-246-5 |2 doi | |
035 | |a (ZDB-2-PRO)978-1-59745-246-5 | ||
035 | |a (OCoLC)724391042 | ||
035 | |a (DE-599)BVBBV044950958 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-91 | ||
050 | 0 | |a QR177 | |
082 | 0 | |a 616.9041 |2 22 | |
082 | 0 | |a 616.9 |2 23 | |
084 | |a XI 3500 |0 (DE-625)152997:12905 |2 rvk | ||
084 | |a XI 3511 |0 (DE-625)152997:12917 |2 rvk | ||
245 | 1 | 0 | |a New Antibiotic Targets |c edited by W. Scott Champney |
264 | 1 | |a Totowa, NJ |b Humana Press |c 2008 | |
300 | |a 1 Online-Ressource (XII, 274 p. 51 illus) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Methods In Molecular Medicine™ |v 142 | |
520 | |a A crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In "New Antibiotic Targets," W. Scott Champney examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies. With detailed methods and protocols for the identification and assay of these targets, "New Antibiotic Targets" provides laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases | ||
650 | 4 | |a Medicine & Public Health | |
650 | 4 | |a Infectious Diseases | |
650 | 4 | |a Immunology | |
650 | 4 | |a Molecular Medicine | |
650 | 4 | |a Virology | |
650 | 4 | |a Medicine | |
650 | 4 | |a Immunology | |
650 | 4 | |a Molecular biology | |
650 | 4 | |a Virology | |
650 | 4 | |a Infectious diseases | |
650 | 0 | 7 | |a Antibiotikum |0 (DE-588)4002257-2 |2 gnd |9 rswk-swf |
655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Antibiotikum |0 (DE-588)4002257-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Champney, W. Scott |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781588299154 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-59745-246-5 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-PRO | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-030343717 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://doi.org/10.1007/978-1-59745-246-5 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1007/978-1-59745-246-5 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804178539021336576 |
---|---|
any_adam_object | |
author2 | Champney, W. Scott |
author2_role | edt |
author2_variant | w s c ws wsc |
author_facet | Champney, W. Scott |
building | Verbundindex |
bvnumber | BV044950958 |
callnumber-first | Q - Science |
callnumber-label | QR177 |
callnumber-raw | QR177 |
callnumber-search | QR177 |
callnumber-sort | QR 3177 |
callnumber-subject | QR - Microbiology |
classification_rvk | XI 3500 XI 3511 |
collection | ZDB-2-PRO |
ctrlnum | (ZDB-2-PRO)978-1-59745-246-5 (OCoLC)724391042 (DE-599)BVBBV044950958 |
dewey-full | 616.9041 616.9 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.9041 616.9 |
dewey-search | 616.9041 616.9 |
dewey-sort | 3616.9041 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-59745-246-5 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03093nmm a2200601zcb4500</leader><controlfield tag="001">BV044950958</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180829 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180517s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781597452465</subfield><subfield code="9">978-1-59745-246-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-59745-246-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-59745-246-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)724391042</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044950958</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR177</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9041</subfield><subfield code="2">22</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 3500</subfield><subfield code="0">(DE-625)152997:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 3511</subfield><subfield code="0">(DE-625)152997:12917</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New Antibiotic Targets</subfield><subfield code="c">edited by W. Scott Champney</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XII, 274 p. 51 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods In Molecular Medicine™</subfield><subfield code="v">142</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In "New Antibiotic Targets," W. Scott Champney examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies. With detailed methods and protocols for the identification and assay of these targets, "New Antibiotic Targets" provides laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine & Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular biology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious diseases</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antibiotikum</subfield><subfield code="0">(DE-588)4002257-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antibiotikum</subfield><subfield code="0">(DE-588)4002257-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Champney, W. Scott</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781588299154</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-59745-246-5</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030343717</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-59745-246-5</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-59745-246-5</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV044950958 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:05:34Z |
institution | BVB |
isbn | 9781597452465 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030343717 |
oclc_num | 724391042 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (XII, 274 p. 51 illus) |
psigel | ZDB-2-PRO |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | Humana Press |
record_format | marc |
series2 | Methods In Molecular Medicine™ |
spelling | New Antibiotic Targets edited by W. Scott Champney Totowa, NJ Humana Press 2008 1 Online-Ressource (XII, 274 p. 51 illus) txt rdacontent c rdamedia cr rdacarrier Methods In Molecular Medicine™ 142 A crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In "New Antibiotic Targets," W. Scott Champney examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies. With detailed methods and protocols for the identification and assay of these targets, "New Antibiotic Targets" provides laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases Medicine & Public Health Infectious Diseases Immunology Molecular Medicine Virology Medicine Molecular biology Infectious diseases Antibiotikum (DE-588)4002257-2 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Antibiotikum (DE-588)4002257-2 s DE-604 Champney, W. Scott edt Erscheint auch als Druck-Ausgabe 9781588299154 https://doi.org/10.1007/978-1-59745-246-5 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | New Antibiotic Targets Medicine & Public Health Infectious Diseases Immunology Molecular Medicine Virology Medicine Molecular biology Infectious diseases Antibiotikum (DE-588)4002257-2 gnd |
subject_GND | (DE-588)4002257-2 (DE-588)4143413-4 |
title | New Antibiotic Targets |
title_auth | New Antibiotic Targets |
title_exact_search | New Antibiotic Targets |
title_full | New Antibiotic Targets edited by W. Scott Champney |
title_fullStr | New Antibiotic Targets edited by W. Scott Champney |
title_full_unstemmed | New Antibiotic Targets edited by W. Scott Champney |
title_short | New Antibiotic Targets |
title_sort | new antibiotic targets |
topic | Medicine & Public Health Infectious Diseases Immunology Molecular Medicine Virology Medicine Molecular biology Infectious diseases Antibiotikum (DE-588)4002257-2 gnd |
topic_facet | Medicine & Public Health Infectious Diseases Immunology Molecular Medicine Virology Medicine Molecular biology Infectious diseases Antibiotikum Aufsatzsammlung |
url | https://doi.org/10.1007/978-1-59745-246-5 |
work_keys_str_mv | AT champneywscott newantibiotictargets |